Department of Pathology, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan
Received December 8, 2010; accepted December 11, 2010; Epub November 12, 2010; published January 1, 2011
Abstract: Bronchioloalveolar carcinoma (BAC) arising in the peripheral lung is the prototype of human lung adenocarcinoma and is considered to develop, at least in part, from its precursor atypical adenomatous hyperplasia (AAH). Molecular genetics investigations have revealed the significant roles of mutations in KRAS and epidermal growth factor receptor (EGFR) genes in the pathogenesis of AAH and BAC. Recently, selective molecular targeting therapies, such as those using EGFR tyrosine kinase inhibitors, have been introduced with remarkable success. In spite of the accumulation of research results into BAC/AAH, there remain three important issues to be addressed; 1) the etiology of BAC and AAH, 2) the genetic and/or epigenetic alteration(s) responsible for the progression of AAH to BAC, 3) the genetic backgrounds speculated as the cause of multiple AAH/BAC. These three issues are briefly reviewed and discussed, along with the murine pulmonary carcinogenesis model which is potentially useful for solving these issues. (IJCEP1012006).
Address all correspondence to: Hitoshi Kitamura, MD, PhD Department of Pathology Graduate School of Medicine Yokohama City University 3-9 Fukuura, Kanazawa-ku Yokohama 236-0004, Japan Tel: +81-45-787-2583 Fax: +81-45-789-0588 E-mail: email@example.com